group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00162,0.3200107230205929,FUN_000620-T1,Peve_00017114,Pocillopora_meandrina_HIv1___RNAseq.g1866.t1,three_way,76.233,FUN_000620-T1,O95427,PIGN_HUMAN,,GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N),Homo sapiens (Human),53.5,939.0,5.1999999999999995e-264,912.1,sp|O95427|PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens OX=9606 GN=PIGN PE=1 SV=1,GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0051377,GPI anchor biosynthetic process [GO:0006506],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],mannose-ethanolamine phosphotransferase activity [GO:0051377],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:1901135,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_00390,0.3863747523802309,FUN_001246-T1,Peve_00037027,Pocillopora_meandrina_HIv1___RNAseq.g2298.t1,three_way,69.81466666666667,FUN_001246-T1,Q7LL04,,,,,34.3,297.0,3.9e-30,133.7,sp|Q7LL04|YQK1_SCHPO UPF0676 protein C1494.01 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC1494.01 PE=3 SV=2,,,,,,
OG_00450,0.1635137962324157,FUN_001370-T2,Peve_00025098,Pocillopora_meandrina_HIv1___RNAseq.g2140.t1,three_way,55.64983333333333,FUN_001370-T2,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),39.1,422.0,6.900000000000001e-67,257.3,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_00483,0.7048934837507193,FUN_001447-T1,Peve_00019961,Pocillopora_meandrina_HIv1___RNAseq.g1952.t1,three_way,57.163,FUN_001447-T1,Q61824,,,,,37.3,714.0,8.5e-130,466.5,sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2,,,,,,
OG_00829,0.2741121664496826,FUN_004060-T1,Peve_00028225,Pocillopora_meandrina_HIv1___RNAseq.g17246.t2,three_way,51.38283333333333,FUN_004060-T1,O97827,,,,,33.2,554.0,1.4000000000000001e-74,282.3,sp|O97827|AGRL3_BOVIN Adhesion G protein-coupled receptor L3 OS=Bos taurus OX=9913 GN=ADGRL3 PE=2 SV=1,,,,,,
OG_00987,0.0996110215092821,FUN_004374-T1,Peve_00008061,Pocillopora_meandrina_HIv1___RNAseq.g16620.t1,three_way,61.492666666666665,FUN_004374-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),58.1,210.0,8.2e-11,68.9,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_01157,0.1805016359862128,FUN_004768-T1,Peve_00002138,Pocillopora_meandrina_HIv1___RNAseq.g6696.t1,three_way,59.955666666666666,FUN_004768-T1,Q9UDY8,MALT1_HUMAN,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),Homo sapiens (Human),29.2,713.0,3.7e-62,241.1,sp|Q9UDY8|MALT1_HUMAN Mucosa-associated lymphoid tissue lymphoma translocation protein 1 OS=Homo sapiens OX=9606 GN=MALT1 PE=1 SV=1,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051168; GO:0051603; GO:0061133; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01181,0.3954625440290461,FUN_004831-T2,Peve_00013711,Pocillopora_meandrina_HIv1___RNAseq.g8583.t1,three_way,66.76283333333333,,,,,,,,,,,,,,,,,
OG_01455,0.1959705424104066,FUN_005913-T1,Peve_00008487,Pocillopora_meandrina_HIv1___RNAseq.g19569.t1,three_way,86.37333333333333,FUN_005913-T1,Q922V4,,,,,67.2,497.0,3.8999999999999996e-90,333.6,sp|Q922V4|PLRG1_MOUSE Pleiotropic regulator 1 OS=Mus musculus OX=10090 GN=Plrg1 PE=1 SV=1,,,,,,
OG_01759,0.32239570593756,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_01918,0.6095457968827585,FUN_007947-T1,Peve_00021143,Pocillopora_meandrina_HIv1___TS.g21111.t2,three_way,56.5525,,,,,,,,,,,,,,,,,
OG_02050,0.2538704645220471,FUN_008260-T1,Peve_00042074,Pocillopora_meandrina_HIv1___RNAseq.g17965.t1,three_way,81.01316666666668,FUN_008260-T1,P59325,,,,,52.8,390.0,5e-105,382.9,sp|P59325|IF5_MOUSE Eukaryotic translation initiation factor 5 OS=Mus musculus OX=10090 GN=Eif5 PE=1 SV=1,,,,,,
OG_02198,0.4782090019634802,FUN_008562-T1,Peve_00044733,Pocillopora_meandrina_HIv1___TS.g25491.t1,three_way,80.36,,,,,,,,,,,,,,,,,
OG_02454,0.6997260349511836,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_02473,0.529084722528709,FUN_009675-T1,Peve_00009262,Pocillopora_meandrina_HIv1___RNAseq.g24569.t1,three_way,75.73666666666666,FUN_009675-T1,Q8K078,SO4A1_MOUSE,,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),Mus musculus (Mouse),38.1,637.0,2.3e-114,414.5,sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2,GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015711,monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711],plasma membrane [GO:0005886],organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_02935,0.2551458560399364,FUN_012040-T1,Peve_00016079,Pocillopora_meandrina_HIv1___RNAseq.g24061.t1,three_way,58.10066666666667,,,,,,,,,,,,,,,,,
OG_03306,0.312181486625841,FUN_013378-T1,Peve_00020455,Pocillopora_meandrina_HIv1___RNAseq.g22985.t2,three_way,65.02866666666667,FUN_013378-T1,Q5QD15,TAAR4_MOUSE,,Trace amine-associated receptor 4 (TaR-4) (Trace amine receptor 4) (mTaar4) (2-phenylethylamine receptor),Mus musculus (Mouse),26.1,272.0,6.8e-16,86.7,sp|Q5QD15|TAAR4_MOUSE Trace amine-associated receptor 4 OS=Mus musculus OX=10090 GN=Taar4 PE=1 SV=1,GO:0001594; GO:0001662; GO:0005886; GO:0007606; GO:0007635; GO:0008227; GO:1990080,behavioral fear response [GO:0001662]; chemosensory behavior [GO:0007635]; sensory perception of chemical stimulus [GO:0007606],plasma membrane [GO:0005886],2-phenylethylamine receptor activity [GO:1990080]; G protein-coupled amine receptor activity [GO:0008227]; trace-amine receptor activity [GO:0001594],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_03364,0.3307152704462487,FUN_013606-T1,Peve_00002653,Pocillopora_meandrina_HIv1___RNAseq.g13526.t1,three_way,79.673,FUN_013606-T1,Q60HE5,,,,,52.4,614.0,6.400000000000001e-186,652.1,sp|Q60HE5|MTHR_MACFA Methylenetetrahydrofolate reductase (NADPH) OS=Macaca fascicularis OX=9541 GN=MTHFR PE=2 SV=1,,,,,,
OG_03580,0.2154744388951432,FUN_014735-T1,Peve_00010434,Pocillopora_meandrina_HIv1___RNAseq.g22482.t1,three_way,69.71300000000001,FUN_014735-T1,O15400,STX7_HUMAN,,Syntaxin-7,Homo sapiens (Human),38.0,221.0,1.3e-21,105.1,sp|O15400|STX7_HUMAN Syntaxin-7 OS=Homo sapiens OX=9606 GN=STX7 PE=1 SV=4,GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076,intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982],chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006886; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0098772,lysosome; endosome; vacuole; plasma membrane; intracellular protein transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_03895,0.299119289571264,FUN_015470-T1,Peve_00009523,Pocillopora_meandrina_HIv1___RNAseq.g20981.t1,three_way,61.727,FUN_015470-T1,Q12872,SFSWA_HUMAN,,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",Homo sapiens (Human),40.4,451.0,5e-19,97.8,"sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3",GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]",nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03980,0.2926129801425707,FUN_016138-T1,Peve_00022583,Pocillopora_meandrina_HIv1___RNAseq.g22031.t2,three_way,68.26350000000001,FUN_016138-T1,Q9ER33,CNGA3_RAT,,Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3) (Gustatory cyclic nucleotide-gated cation channel) (CNGgust),Rattus norvegicus (Rat),42.4,224.0,1.1999999999999999e-41,172.2,sp|Q9ER33|CNGA3_RAT Cyclic nucleotide-gated channel alpha-3 OS=Rattus norvegicus OX=10116 GN=Cnga3 PE=1 SV=1,GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0006814; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0034220; GO:0043025; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0046549; GO:0051591; GO:0051899; GO:0060041; GO:0097386; GO:0098655; GO:0098659; GO:0120199; GO:1902495,inorganic cation import across plasma membrane [GO:0098659]; membrane depolarization [GO:0051899]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; sodium ion transport [GO:0006814],axon initial segment [GO:0043194]; cone photoreceptor outer segment [GO:0120199]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495],cadherin binding [GO:0045296]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; myosin binding [GO:0017022]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0008092; GO:0048856; GO:0055085,transporter activity; plasma membrane; cytoskeletal protein binding; anatomical structure development; transmembrane transport
OG_04233,0.1520979955921443,FUN_017710-T1,Peve_00005948,Pocillopora_meandrina_HIv1___RNAseq.g25375.t1,three_way,60.20766666666667,FUN_017710-T1,P0DXC0,,,,,43.8,336.0,8.8e-67,256.5,sp|P0DXC0|CGLR3_STYPI Cyclic GMP-AMP synthase-like receptor 3 OS=Stylophora pistillata OX=50429 PE=1 SV=1,,,,,,
OG_04247,0.2952065337621302,FUN_017773-T1,Peve_00016058,Pocillopora_meandrina_HIv1___RNAseq.g448.t1,three_way,76.1215,FUN_017773-T1,P48746,,,,,41.1,915.0,2.4000000000000002e-182,641.0,sp|P48746|B3A2_RABIT Anion exchange protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC4A2 PE=1 SV=1,,,,,,
OG_04252,0.3413216748118657,FUN_017782-T1,Peve_00029910,Pocillopora_meandrina_HIv1___TS.g23048.t1,three_way,68.84083333333334,FUN_017782-T1,P77952,,,,,33.3,129.0,1.6e-06,55.8,sp|P77952|GLSA_STRGR L-glutamine:scyllo-inosose aminotransferase OS=Streptomyces griseus OX=1911 GN=stsC PE=1 SV=1,,,,,,
OG_04291,0.156626109169316,FUN_017854-T1,Peve_00019169,Pocillopora_meandrina_HIv1___RNAseq.g20298.t1,three_way,61.41483333333333,FUN_017854-T1,P09875,UD2B1_RAT,,UDP-glucuronosyltransferase 2B1 (UDPGT 2B1) (UGT2B1) (EC 2.4.1.17) (UDPGTr-2),Rattus norvegicus (Rat),34.3,505.0,7.5e-76,286.2,sp|P09875|UD2B1_RAT UDP-glucuronosyltransferase 2B1 OS=Rattus norvegicus OX=10116 GN=Ugt2b1 PE=1 SV=1,GO:0005789; GO:0006805; GO:0008210; GO:0015020; GO:0032496; GO:0070980; GO:0071361; GO:0071378; GO:0071385; GO:0071394,biphenyl catabolic process [GO:0070980]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to testosterone stimulus [GO:0071394]; estrogen metabolic process [GO:0008210]; response to lipopolysaccharide [GO:0032496]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],glucuronosyltransferase activity [GO:0015020],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_04687,0.2148753929588668,FUN_022478-T1,Peve_00002929,Pocillopora_meandrina_HIv1___RNAseq.g4301.t1,three_way,36.67283333333333,,,,,,,,,,,,,,,,,
OG_04747,0.8119643520174326,FUN_022630-T1,Peve_00012283,Pocillopora_meandrina_HIv1___RNAseq.g2910.t1,three_way,68.43933333333334,FUN_022630-T1,P07228,,,,,38.2,815.0,1.2e-144,515.4,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_04782,0.3048511852947678,FUN_022693-T1,Peve_00045100,Pocillopora_meandrina_HIv1___RNAseq.g4832.t1,three_way,44.72983333333333,,,,,,,,,,,,,,,,,
OG_04837,0.209510700723447,FUN_022835-T1,Peve_00020479,Pocillopora_meandrina_HIv1___TS.g9598.t1,three_way,64.63833333333334,,,,,,,,,,,,,,,,,
OG_04838,0.2551683671214242,FUN_022837-T1,Peve_00028887,Pocillopora_meandrina_HIv1___RNAseq.g3399.t1,three_way,45.176,,,,,,,,,,,,,,,,,
OG_05169,0.3831338228313442,FUN_023497-T1,Peve_00017459,Pocillopora_meandrina_HIv1___RNAseq.g539.t1,three_way,83.72433333333333,FUN_023497-T1,Q7T292,,,,,56.8,301.0,4.9e-98,359.4,sp|Q7T292|MFRN2_DANRE Mitoferrin-2 OS=Danio rerio OX=7955 GN=slc25a28 PE=2 SV=1,,,,,,
OG_05294,0.6459127263852386,FUN_023962-T1,Peve_00043985,Pocillopora_meandrina_HIv1___RNAseq.g18585.t1,three_way,84.302,,,,,,,,,,,,,,,,,
OG_05347,0.2792748008647501,FUN_024110-T1,Peve_00000187,Pocillopora_meandrina_HIv1___RNAseq.g19190.t1,three_way,60.88066666666666,FUN_024110-T1,P30874,SSR2_HUMAN,,Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SST2) (SRIF-1),Homo sapiens (Human),23.1,337.0,2e-13,78.6,sp|P30874|SSR2_HUMAN Somatostatin receptor type 2 OS=Homo sapiens OX=9606 GN=SSTR2 PE=1 SV=1,GO:0004994; GO:0005654; GO:0005829; GO:0005886; GO:0007187; GO:0007193; GO:0007218; GO:0008285; GO:0030165; GO:0042923; GO:0043005; GO:0071385; GO:0071392,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]",cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994],GO:0005654; GO:0005829; GO:0005886; GO:0060089,nucleoplasm; cytosol; plasma membrane; molecular transducer activity
OG_05457,0.7890580208706451,FUN_024418-T1,Peve_00029260,Pocillopora_meandrina_HIv1___RNAseq.g18720.t1,three_way,74.32566666666666,FUN_024418-T1,Q98SN7,,,,,55.1,345.0,5e-110,399.4,sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1,,,,,,
OG_05502,0.3722419274878914,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.3000000000000025e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05506,0.6339972920210262,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_05508,0.2598999087591712,FUN_024589-T1,Peve_00007645,Pocillopora_meandrina_HIv1___RNAseq.g19110.t1,three_way,77.43599999999999,FUN_024589-T1,Q96EY1,DNJA3_HUMAN,,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",Homo sapiens (Human),42.7,424.0,7.7e-85,315.8,"sp|Q96EY1|DNJA3_HUMAN DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2",GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008270; GO:0008285; GO:0009408; GO:0009898; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043231; GO:0044877; GO:0045211; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297,activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase-mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; type II interferon receptor binding [GO:0005133]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005739; GO:0005829; GO:0006260; GO:0006355; GO:0006457; GO:0007005; GO:0012501; GO:0030154; GO:0034330; GO:0043226; GO:0098772,immune system process; nucleus; mitochondrion; cytosol; DNA replication; regulation of DNA-templated transcription; protein folding; mitochondrion organization; programmed cell death; cell differentiation; cell junction organization; organelle; molecular function regulator activity
OG_05676,0.214062730367192,FUN_025507-T1,Peve_00036821,Pocillopora_meandrina_HIv1___RNAseq.g13214.t1,three_way,61.089,FUN_025507-T1,P17124,,,,,30.4,280.0,6.5e-16,86.3,sp|P17124|HRH2_CANLF Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1,,,,,,
OG_05718,0.7158631525690535,FUN_025610-T1,Peve_00009537,Pocillopora_meandrina_HIv1___RNAseq.g23128.t1,three_way,58.688833333333335,FUN_025610-T1,Q07497,,,,,34.9,935.0,3.6999999999999996e-147,523.9,sp|Q07497|EPHB5_CHICK Ephrin type-B receptor 5 OS=Gallus gallus OX=9031 GN=EPHB5 PE=2 SV=1,,,,,,
OG_05724,0.3890375188801984,FUN_025643-T1,Peve_00002527,Pocillopora_meandrina_HIv1___TS.g15983.t1,three_way,64.00683333333333,FUN_025643-T1,Q04637,IF4G1_HUMAN,,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),Homo sapiens (Human),39.4,1020.0,1.2e-159,566.2,sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4,GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606; GO:1905612,behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840],"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]",GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; nucleus; cytosol; ribosome; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_05811,0.1538076327933599,FUN_025813-T1,Peve_00002522,Pocillopora_meandrina_HIv1___RNAseq.g9335.t1,three_way,47.96866666666666,,,,,,,,,,,,,,,,,
OG_06021,0.2428444686094406,FUN_026556-T3,Peve_00043079,Pocillopora_meandrina_HIv1___RNAseq.g4518.t1,three_way,60.15483333333333,,,,,,,,,,,,,,,,,
OG_06101,0.2975419931063485,FUN_027779-T1,Peve_00034984,Pocillopora_meandrina_HIv1___RNAseq.g12667.t1,three_way,61.244166666666665,FUN_027779-T1,Q7Z408,CSMD2_HUMAN,,CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2),Homo sapiens (Human),23.2,921.0,4.8e-24,116.7,sp|Q7Z408|CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CSMD2 PE=1 SV=2,GO:0097107; GO:0098839; GO:0098978; GO:0099562,maintenance of postsynaptic density structure [GO:0099562]; postsynaptic density assembly [GO:0097107],glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839],,GO:0034330,cell junction organization
OG_06274,0.1343476340896564,FUN_028311-T1,Peve_00037729,Pocillopora_meandrina_HIv1___RNAseq.g16423.t1,three_way,51.885,,,,,,,,,,,,,,,,,
OG_06329,0.2047335286023393,FUN_028877-T1,Peve_00044602,Pocillopora_meandrina_HIv1___RNAseq.g12808.t1,three_way,91.02266666666668,FUN_028877-T1,Q28FE4,,,,,80.5,113.0,2.1e-56,219.9,sp|Q28FE4|MORN5_XENTR MORN repeat-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=morn5 PE=2 SV=1,,,,,,
OG_06341,0.2202787997279505,FUN_028906-T1,Peve_00031963,Pocillopora_meandrina_HIv1___RNAseq.g25670.t1,three_way,85.42666666666668,FUN_028906-T1,O00429,DNM1L_HUMAN,,Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),Homo sapiens (Human),60.5,770.0,7.5e-242,838.2,sp|O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens OX=9606 GN=DNM1L PE=1 SV=2,GO:0000266; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043231; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0160040; GO:1900063; GO:1901524; GO:1903578,calcium ion transport [GO:0006816]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion organization [GO:0007005]; mitocytosis [GO:0160040]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; regulation of peroxisome organization [GO:1900063]; rhythmic process [GO:0048511],brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625],GO:0003013; GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0061024; GO:0065003; GO:0098772,circulatory system process; catalytic activity; GTPase activity; mitochondrion; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; membrane organization; protein-containing complex assembly; molecular function regulator activity
OG_06346,0.1864717308788529,FUN_028912-T1,Peve_00041442,Pocillopora_meandrina_HIv1___RNAseq.g22342.t1,three_way,75.41166666666666,FUN_028912-T1,Q96DF8,ESS2_HUMAN,,Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2),Homo sapiens (Human),39.3,458.0,2.7e-72,274.2,sp|Q96DF8|ESS2_HUMAN Splicing factor ESS-2 homolog OS=Homo sapiens OX=9606 GN=ESS2 PE=1 SV=1,GO:0000398; GO:0005634; GO:0007399; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634],,GO:0005634; GO:0016071; GO:0043226; GO:0048856,nucleus; mRNA metabolic process; organelle; anatomical structure development
OG_06561,0.624564950812558,FUN_029445-T1,Peve_00025077,Pocillopora_meandrina_HIv1___RNAseq.g17165.t1,three_way,60.66566666666667,FUN_029445-T1,Q6IQH6,,,,,34.5,232.0,2.4e-29,131.0,sp|Q6IQH6|PLPR1_DANRE Phospholipid phosphatase-related protein type 1 OS=Danio rerio OX=7955 GN=plppr1 PE=2 SV=1,,,,,,
OG_06608,0.4254957658925621,FUN_029758-T1,Peve_00019497,Pocillopora_meandrina_HIv1___TS.g3083.t1,three_way,75.64366666666666,FUN_029758-T1,O75694,NU155_HUMAN,,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),Homo sapiens (Human),46.4,1399.0,0.0,1191.4,sp|O75694|NU155_HUMAN Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1,GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0035196; GO:0036228; GO:0044611; GO:0086014,atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913; GO:0061024,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport; membrane organization
OG_06622,0.7307012628923995,FUN_029891-T1,Peve_00008454,Pocillopora_meandrina_HIv1___RNAseq.g17343.t1,three_way,56.2075,FUN_029891-T1,O15146,,,,,37.1,318.0,1.7e-61,239.2,"sp|O15146|MUSK_HUMAN Muscle, skeletal receptor tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=MUSK PE=1 SV=1",,,,,,
OG_06653,0.3257753309241802,FUN_030678-T1,Peve_00028161,Pocillopora_meandrina_HIv1___RNAseq.g6203.t1,three_way,43.779,,,,,,,,,,,,,,,,,
OG_06976,0.2762988824505102,FUN_032111-T1,Peve_00030228,Pocillopora_meandrina_HIv1___RNAseq.g5390.t1,three_way,72.92066666666666,FUN_032111-T1,A6H630,ARMT1_MOUSE,,Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1),Mus musculus (Mouse),46.2,439.0,2.2999999999999997e-105,384.0,sp|A6H630|ARMT1_MOUSE Damage-control phosphatase ARMT1 OS=Mus musculus OX=10090 GN=Armt1 PE=1 SV=1,GO:0006974; GO:0008757; GO:0008983; GO:0019899; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026,DNA damage response [GO:0006974]; methylation [GO:0032259],,enzyme binding [GO:0019899]; fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; protein carboxyl O-methyltransferase activity [GO:0051998]; protein-glutamate O-methyltransferase activity [GO:0008983]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0016740; GO:0016787; GO:0016829; GO:0140096,"catalytic activity; transferase activity; hydrolase activity; lyase activity; catalytic activity, acting on a protein"
OG_07250,0.5670776834313108,FUN_032992-T1,Peve_00014540,Pocillopora_meandrina_HIv1___RNAseq.g24473.t1,three_way,73.003,FUN_032992-T1,Q8RCT3,,,,,57.0,302.0,2.5e-88,328.2,sp|Q8RCT3|PSUG_CALS4 Pseudouridine-5'-phosphate glycosidase OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=psuG PE=3 SV=1,,,,,,
OG_07573,0.2107973149064649,FUN_034245-T1,Peve_00003830,Pocillopora_meandrina_HIv1___RNAseq.g26610.t1c,three_way,49.638666666666666,FUN_034245-T1,P07949,RET_HUMAN,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Homo sapiens (Human),40.5,328.0,3.6e-57,224.6,sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0010008; GO:0010628; GO:0010976; GO:0030155; GO:0030335; GO:0030424; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:0160144; GO:2001241,axon guidance [GO:0007411]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; posterior midgut development [GO:0007497]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; signal transduction [GO:0007165]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"immune system process; catalytic activity; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_07578,0.0893611348995822,FUN_034259-T1,Peve_00009314,Pocillopora_meandrina_HIv1___RNAseq.g26619.t1,three_way,51.376333333333335,,,,,,,,,,,,,,,,,
OG_07816,0.1824970377661712,FUN_035068-T1,Peve_00026040,Pocillopora_meandrina_HIv1___RNAseq.g27722.t1,three_way,68.704,FUN_035068-T1,Q5U403,MVD1_DANRE,,Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase),Danio rerio (Zebrafish) (Brachydanio rerio),54.7,391.0,7.4e-119,428.7,sp|Q5U403|MVD1_DANRE Diphosphomevalonate decarboxylase OS=Danio rerio OX=7955 GN=mvd PE=2 SV=1,GO:0003334; GO:0004163; GO:0005524; GO:0005829; GO:0006695; GO:0019287; GO:0045765,"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; keratinocyte development [GO:0003334]; regulation of angiogenesis [GO:0045765]",cytosol [GO:0005829],ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0016829; GO:0048856; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; lyase activity; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_07882,0.3778637934395961,FUN_035257-T1,Peve_00032647,Pocillopora_meandrina_HIv1___RNAseq.g27885.t1,three_way,70.81866666666667,FUN_035257-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.3,1072.0,9.4e-262,904.8,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_07907,0.4431260934339923,FUN_035351-T1,Peve_00016239,Pocillopora_meandrina_HIv1___RNAseq.g12260.t1,three_way,72.70233333333333,FUN_035351-T1,Q6XPZ3,PAG15_CANLF,,Lysosomal phospholipase A and acyltransferase (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2) (Phospholipase A2 group XV),Canis lupus familiaris (Dog) (Canis familiaris),40.4,394.0,2.3999999999999998e-82,307.4,sp|Q6XPZ3|PAG15_CANLF Lysosomal phospholipase A and acyltransferase OS=Canis lupus familiaris OX=9615 GN=PLA2G15 PE=1 SV=1,GO:0004622; GO:0005615; GO:0005654; GO:0005764; GO:0006631; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0016020; GO:0016411; GO:0034638; GO:0046338; GO:0046470; GO:0046471; GO:0047499,ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658],extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654],acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipase A1 activity [GO:0008970]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005654; GO:0005764; GO:0005773; GO:0006575; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; nucleoplasm; lysosome; vacuole; modified amino acid metabolic process; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_07989,0.2733758892076042,FUN_035619-T1,Peve_00029652,Pocillopora_meandrina_HIv1___TS.g15424.t1,three_way,51.177,,,,,,,,,,,,,,,,,
OG_08082,0.1053368902965438,FUN_035806-T1,Peve_00021611,Pocillopora_meandrina_HIv1___RNAseq.g11923.t1,three_way,62.91633333333333,FUN_035806-T1,Q1GRQ3,,,,,30.4,181.0,4.2e-13,76.6,sp|Q1GRQ3|RRF_SPHAL Ribosome-recycling factor OS=Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) OX=317655 GN=frr PE=3 SV=1,,,,,,
OG_08167,0.275756327800111,FUN_035969-T1,Peve_00045085,Pocillopora_meandrina_HIv1___RNAseq.g12339.t1,three_way,87.10833333333333,FUN_035969-T1,Q6GR45,,,,,81.2,245.0,5.7e-114,411.8,sp|Q6GR45|IF6_XENLA Eukaryotic translation initiation factor 6 OS=Xenopus laevis OX=8355 GN=eif6 PE=2 SV=1,,,,,,
OG_08279,0.1129207121965718,FUN_036200-T1,Peve_00011078,Pocillopora_meandrina_HIv1___RNAseq.g27365.t1,three_way,49.842666666666666,,,,,,,,,,,,,,,,,
OG_08304,0.4230104787083777,FUN_036258-T1,Peve_00032885,Pocillopora_meandrina_HIv1___RNAseq.g27585.t1,three_way,77.87166666666667,FUN_036258-T1,Q8BYI6,PCAT2_MOUSE,,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1),Mus musculus (Mouse),48.2,475.0,1.2e-123,444.9,sp|Q8BYI6|PCAT2_MOUSE Lysophosphatidylcholine acyltransferase 2 OS=Mus musculus OX=10090 GN=Lpcat2 PE=1 SV=1,GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016020; GO:0036151; GO:0047159; GO:0047184; GO:0047192; GO:0061024,membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0047159],GO:0003824; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0016740; GO:0043226; GO:0061024,catalytic activity; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; transferase activity; organelle; membrane organization
OG_08411,0.3934897585868822,FUN_037062-T1,Peve_00018396,Pocillopora_meandrina_HIv1___RNAseq.g26779.t1,three_way,65.08266666666667,FUN_037062-T1,O95628,CNOT4_HUMAN,,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),Homo sapiens (Human),48.8,441.0,2.6e-103,377.9,sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3,GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634],RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08661,0.6384297233855983,FUN_037877-T1,Peve_00027466,Pocillopora_meandrina_HIv1___TS.g13174.t1,three_way,47.705333333333336,FUN_037877-T1,P86733,,,,,41.8,110.0,7.4e-27,125.6,sp|P86733|KCP_HALAI BPTI/Kunitz domain-containing protein (Fragment) OS=Haliotis asinina OX=109174 PE=1 SV=1,,,,,,
OG_08811,0.137614840832382,FUN_038134-T1,Peve_00043379,Pocillopora_meandrina_HIv1___RNAseq.g764.t1,three_way,80.85533333333333,FUN_038134-T1,Q8L7C8,RWA1_ARATH,,Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-),Arabidopsis thaliana (Mouse-ear cress),42.3,433.0,1.8000000000000002e-81,305.1,sp|Q8L7C8|RWA1_ARATH Protein REDUCED WALL ACETYLATION 1 OS=Arabidopsis thaliana OX=3702 GN=RWA1 PE=2 SV=1,GO:0000139; GO:0005794; GO:0009834; GO:0016491; GO:0016740; GO:0045491; GO:0045492; GO:1990937,plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740],GO:0003824; GO:0005794; GO:0005975; GO:0016491; GO:0016740; GO:0043226; GO:0071554,catalytic activity; Golgi apparatus; carbohydrate metabolic process; oxidoreductase activity; transferase activity; organelle; cell wall organization or biogenesis
OG_08844,0.3508905961539964,FUN_038195-T1,Peve_00008324,Pocillopora_meandrina_HIv1___RNAseq.g939.t1,three_way,54.577666666666666,,,,,,,,,,,,,,,,,
OG_08874,0.2417326815233866,FUN_038271-T1,Peve_00010406,Pocillopora_meandrina_HIv1___RNAseq.g28323.t1,three_way,64.48483333333333,FUN_038271-T1,Q7TN88,,,,,29.4,1654.0,3.4e-170,602.1,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_09018,0.1517434430776888,FUN_038583-T1,Peve_00010568,Pocillopora_meandrina_HIv1___TS.g5537.t1,three_way,51.0455,,,,,,,,,,,,,,,,,
OG_09037,0.5876495166871567,FUN_038638-T1,Peve_00013491,Pocillopora_meandrina_HIv1___RNAseq.g26490.t2,three_way,56.39266666666666,FUN_038638-T1,Q8WXD9,,,,,42.0,143.0,2e-27,126.7,sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1,,,,,,
OG_09645,0.3063313595201817,FUN_041840-T1,Peve_00009640,Pocillopora_meandrina_HIv1___RNAseq.g15080.t1,three_way,69.50733333333334,,,,,,,,,,,,,,,,,
OG_09797,0.6205438224478382,FUN_042605-T1,Peve_00034914,Pocillopora_meandrina_HIv1___RNAseq.g16849.t1a,three_way,81.68166666666667,FUN_042605-T1,Q9QUM7,,,,,46.1,798.0,1.1e-204,714.9,sp|Q9QUM7|MSH5_MOUSE MutS protein homolog 5 OS=Mus musculus OX=10090 GN=Msh5 PE=1 SV=1,,,,,,
OG_10057,0.3045326989913097,FUN_043351-T1,Peve_00022832,Pocillopora_meandrina_HIv1___TS.g20682.t1,three_way,75.10366666666667,FUN_043351-T1,Q9UJX6,,,,,44.4,762.0,8.299999999999997e-175,615.5,sp|Q9UJX6|ANC2_HUMAN Anaphase-promoting complex subunit 2 OS=Homo sapiens OX=9606 GN=ANAPC2 PE=1 SV=1,,,,,,
OG_10082,0.2637179701271612,FUN_043399-T1,Peve_00024256,Pocillopora_meandrina_HIv1___RNAseq.g9063.t2,three_way,80.929,FUN_043399-T1,Q9NVG8,,,,,60.4,356.0,4.2e-118,426.0,sp|Q9NVG8|TBC13_HUMAN TBC1 domain family member 13 OS=Homo sapiens OX=9606 GN=TBC1D13 PE=1 SV=3,,,,,,
OG_10174,0.5324599030414839,FUN_043583-T1,Peve_00045199,Pocillopora_meandrina_HIv1___RNAseq.g6989.t1,three_way,62.69716666666667,FUN_043583-T1,Q68F67,,,,,45.0,467.0,4.1e-113,410.6,sp|Q68F67|DEN1A_XENLA DENN domain-containing protein 1A OS=Xenopus laevis OX=8355 GN=dennd1a PE=2 SV=1,,,,,,
